Please Wait.....
Report
Middle East & Africa Halal Pharmaceuticals Market Forecast 2025-2032
Market Reprt I 2025-02-01 I 139 Pages I Inkwood Research
KEY FINDINGS
The Middle East & Africa halal pharmaceuticals market is anticipated to rise with a CAGR of 9.32% over the forecast years of 2025 to 2032. The base year regarded for the studied market is 2024, and the forecasting years are from 2025 to 2032.
MARKET INSIGHTS
The halal pharmaceuticals market in the Middle East & Africa has experienced significant growth due to a combination of rising consumer demand and regulatory support. With a large and growing Muslim population, the demand for pharmaceutical products that adhere to halal principles has surged.
Notably, governments across the GCC and African nations have prioritized local production of halal medicines. Saudi Arabia and the UAE are leading initiatives to foster pharmaceutical manufacturing capabilities.
SaudiVax's development of halal vaccines serves as a prime example of these efforts. Opportunities for players in this market are expanding as digital health technologies, and AI are increasingly integrated into local manufacturing processes.
Collaborative partnerships are also on the rise, with investments from countries like China and South Korea into regional pharmaceutical ventures. Regulatory advancements, such as Egypt's and Nigeria's progress in medical product regulation, will further open up opportunities for growth in these emerging markets.
REGIONAL ANALYSIS
The Middle East & Africa halal pharmaceutical industry growth assessment comprises the evaluation of the United Arab Emirates, Saudi Arabia, Turkey, Egypt, South Africa, and Rest of Middle East & Africa.
Halal pharmaceutical certification in Egypt follows rigorous standards outlined by local regulatory bodies like the Egyptian Drug Authority (EDA) to ensure products meet religious and safety requirements. However, challenges persist, particularly in sourcing raw materials that comply with halal standards and ensuring transparent manufacturing processes.
Consumer preferences in Egypt lean towards natural and ethically produced pharmaceuticals, with a focus on safety and religious compliance. The growth potential is amped by the rising adoption of online sales platforms for health and wellness products and an expanding middle-class consumer base seeking premium healthcare options.
In South Africa, the industry is growing, driven by the country's sizable Muslim population and its strategic position in the broader African market. Regulatory frameworks such as the South African Health Products Regulatory Authority (SAHPRA) have set clear standards for halal certification, ensuring products are free from non-halal ingredients and ethically produced.
Market players face challenges, including navigating the complexities of halal certification, particularly when exporting products to countries with more stringent halal standards. Consumer demand is increasingly shifting towards natural health solutions, and there is a growing preference for halal-certified products that offer transparency in sourcing and production.
SEGMENTATION ANALYSIS
The Middle East & Africa halal pharmaceuticals market segmentation includes the market by drug type, dosage form, and distribution channel. The distribution channel segment is further segregated into pharmacies, hospitals and other distribution channels.
The pharmacies sub-segment in the Middle East & Africa market is experiencing robust growth, driven by increasing healthcare demands and evolving consumer preferences. The rise in chronic conditions, an aging population, and improved healthcare accessibility are key factors contributing to this growth.
Recent data indicates strong growth in the retail pharmacy space, particularly in Saudi Arabia, South Africa, and Kenya. This expansion is driven by government investments in healthcare infrastructure and policies to boost pharmaceutical production.
Consumers are increasingly turning to pharmacies for convenient, accessible healthcare solutions, such as over-the-counter medications, prescription drugs, halal healthcare products, and preventive healthcare items. The growing shift toward online pharmacies, powered by rising smartphone penetration and digital literacy, is opening new growth avenues.
Pharmacies in the region are increasingly prioritizing customer convenience, leading to the integration of e-pharmacy models. These models allow consumers to easily order medications and halal healthcare products, with deliveries made directly to their doorsteps, further fuelling the sub-segment's growth.
COMPETITIVE INSIGHTS
Some of the top players operating in the Middle East & Africa halal pharmaceuticals market include Embil Pharmaceuticals Co Ltd, Novartis, Pfizer, Merck, etc.
EMBIL Pharmaceuticals Co Ltd is a leading player in the Middle East & Africa halal pharmaceuticals market. Based in Jordan, the company specializes in producing and distributing high-quality pharmaceutical products that adhere to Islamic principles.
EMBIL's diverse product portfolio includes halal-certified medications designed to meet the dietary and religious needs of consumers. Serving various regional markets across the Middle East & Africa, the company offers medicines across multiple therapeutic areas.
EMBIL's halal pharmaceutical offerings cater to the increasing demand for ethically produced and Sharia-compliant healthcare products.
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. UAE EMERGES AS A DISTRIBUTION HUB FOR HALAL-CERTIFIED DRUGS IN THE REGION
2.5.2. INCREASING CONSUMER PREFERENCE FOR ETHICAL AND CLEAN-LABEL PRODUCTS
2.5.3. GOVERNMENTS ARE INCENTIVIZING THE DEVELOPMENT OF HALAL PHARMACEUTICAL HUBS
2.5.4. GROWING FOCUS ON BIOLOGICS AND BIOSIMILARS IN HALAL FORMULATIONS IS EXPANDING
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING AWARENESS ABOUT HALAL CERTIFICATION AMONG CONSUMERS
3.1.2. GCC MANDATES ARE PROMOTING HALAL COMPLIANCE IN PHARMACEUTICALS
3.2. KEY RESTRAINTS
3.2.1. HIGH COSTS ASSOCIATED WITH HALAL CERTIFICATION AND COMPLIANCE
3.2.2. LIMITED AVAILABILITY OF HALAL-CERTIFIED RAW MATERIALS
3.2.3. REGULATORY INCONSISTENCIES ACROSS DIFFERENT COUNTRIES ARE AFFECTING MARKET ENTRY
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS - HALAL
4.2. KEY MARKET TRENDS
4.2.1. SAUDI ARABIA BOOSTS LOCAL HALAL PHARMACEUTICAL PRODUCTION TO REDUCE IMPORTS
4.2.2. GROWTH IN HALAL HERBAL MEDICINES IN NIGERIA AND SOUTH AFRICA
4.2.3. INCREASING R&D INVESTMENTS IN HALAL BIOPHARMACEUTICALS
4.2.4. RISING COLLABORATIONS BETWEEN PHARMACEUTICAL COMPANIES AND HALAL CERTIFICATION BODIES
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. RAW MATERIAL SOURCING AND CERTIFICATION
4.7.2. RESEARCH AND DEVELOPMENT OF HALAL FORMULATIONS
4.7.3. HALAL-CERTIFIED MANUFACTURING PROCESSES
4.7.4. QUALITY ASSURANCE AND REGULATORY COMPLIANCE
4.7.5. PACKAGING AND LABELING WITH HALAL STANDARDS
4.7.6. DISTRIBUTION AND SUPPLY CHAIN MANAGEMENT
4.7.7. RETAIL AND CONSUMER OUTREACH
4.8. REGULATORY FRAMEWORK AND COMPLIANCE BODIES
5. MARKET BY DRUG TYPE
5.1. ANALGESICS
5.1.1. MARKET FORECAST FIGURE
5.1.2. SEGMENT ANALYSIS
5.2. PAIN MANAGEMENT DRUGS
5.2.1. MARKET FORECAST FIGURE
5.2.2. SEGMENT ANALYSIS
5.3. ANTI-INFLAMMATORY DRUGS
5.3.1. MARKET FORECAST FIGURE
5.3.2. SEGMENT ANALYSIS
5.4. RESPIRATORY DRUGS
5.4.1. MARKET FORECAST FIGURE
5.4.2. SEGMENT ANALYSIS
5.5. CARDIOVASCULAR DRUGS
5.5.1. MARKET FORECAST FIGURE
5.5.2. SEGMENT ANALYSIS
5.6. VACCINES
5.6.1. MARKET FORECAST FIGURE
5.6.2. SEGMENT ANALYSIS
5.7. OTHER DRUG TYPES
5.7.1. MARKET FORECAST FIGURE
5.7.2. SEGMENT ANALYSIS
6. MARKET BY DOSAGE FORM
6.1. SYRUPS
6.1.1. MARKET FORECAST FIGURE
6.1.2. SEGMENT ANALYSIS
6.2. CAPSULES
6.2.1. MARKET FORECAST FIGURE
6.2.2. SEGMENT ANALYSIS
6.3. TABLETS
6.3.1. MARKET FORECAST FIGURE
6.3.2. SEGMENT ANALYSIS
6.4. POWDERS
6.4.1. MARKET FORECAST FIGURE
6.4.2. SEGMENT ANALYSIS
6.5. OTHER DOSAGE FORMS
6.5.1. MARKET FORECAST FIGURE
6.5.2. SEGMENT ANALYSIS
7. MARKET BY DISTRIBUTION CHANNEL
7.1. PHARMACIES
7.1.1. MARKET FORECAST FIGURE
7.1.2. SEGMENT ANALYSIS
7.2. HOSPITALS
7.2.1. MARKET FORECAST FIGURE
7.2.2. SEGMENT ANALYSIS
7.3. OTHER DISTRIBUTION CHANNELS
7.3.1. MARKET FORECAST FIGURE
7.3.2. SEGMENT ANALYSIS
8. GEOGRAPHICAL ANALYSIS
8.1. MIDDLE EAST & AFRICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. COUNTRY ANALYSIS
8.1.2.1. UNITED ARAB EMIRATES
8.1.2.1.1. UNITED ARAB EMIRATES HALAL PHARMACEUTICALS MARKET SIZE & OPPORTUNITIES
8.1.2.2. SAUDI ARABIA
8.1.2.2.1. SAUDI ARABIA HALAL PHARMACEUTICALS MARKET SIZE & OPPORTUNITIES
8.1.2.3. TURKEY
8.1.2.3.1. TURKEY HALAL PHARMACEUTICALS MARKET SIZE & OPPORTUNITIES
8.1.2.4. EGYPT
8.1.2.4.1. EGYPT HALAL PHARMACEUTICALS MARKET SIZE & OPPORTUNITIES
8.1.2.5. SOUTH AFRICA
8.1.2.5.1. SOUTH AFRICA HALAL PHARMACEUTICALS MARKET SIZE & OPPORTUNITIES
8.1.2.6. REST OF MIDDLE EAST & AFRICA
8.1.2.6.1. REST OF MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ABBVIE
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. PRODUCT LIST
9.2.1.3. STRENGTHS & CHALLENGES
9.2.2. BOSCH PHARMACEUTICALS
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCT LIST
9.2.2.3. STRENGTHS & CHALLENGES
9.2.3. CCM PHARMACEUTICALS SDN BHD
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. PRODUCT LIST
9.2.3.3. STRENGTHS & CHALLENGES
9.2.4. CHEMICAL COMPANY OF MALAYSIA BHD
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCT LIST
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. EMBIL PHARMACEUTICALS CO LTD
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. PRODUCT LIST
9.2.5.3. STRENGTHS & CHALLENGES
9.2.6. HOVID
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCT LIST
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. MERCK
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. PRODUCT LIST
9.2.7.3. STRENGTHS & CHALLENGES
9.2.8. NOOR VITAMINS
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCT LIST
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. NOVARTIS
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCT LIST
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. NUTRAMEDICAL INCORPORATED
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. PRODUCT LIST
9.2.10.3. STRENGTHS & CHALLENGES
9.2.11. PFIZER
9.2.11.1. COMPANY OVERVIEW
9.2.11.2. PRODUCT LIST
9.2.11.3. STRENGTHS & CHALLENGES
9.2.12. PHARMANIAGA BHD
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCT LIST
9.2.12.3. STRENGTHS & CHALLENGES
9.2.13. ROSEMONT PHARMACEUTICALS
9.2.13.1. COMPANY OVERVIEW
9.2.13.2. PRODUCT LIST
9.2.13.3. STRENGTHS & CHALLENGES
9.2.14. SANOFI
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCT LIST
9.2.14.3. STRENGTHS & CHALLENGES
9.2.15. SIMPOR PHARMA SENDIRIAN BERHAD
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCT LIST
9.2.15.3. STRENGTHS & CHALLENGES
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - HALAL PHARMACEUTICALS
TABLE 2: REGULATORY FRAMEWORK AND COMPLIANCE BODIES
TABLE 3: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY DRUG TYPE, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
TABLE 4: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY DRUG TYPE, FORECAST YEARS, 2025-2032 (IN $ MILLION)
TABLE 5: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY DOSAGE FORM, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
TABLE 6: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY DOSAGE FORM, FORECAST YEARS, 2025-2032 (IN $ MILLION)
TABLE 7: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
TABLE 8: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2025-2032 (IN $ MILLION)
TABLE 9: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2023 ((IN $ MILLION)
TABLE 10: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY COUNTRY, FORECAST YEARS, 2025-2032 ((IN $ MILLION)
TABLE 11: LIST OF MERGERS & ACQUISITIONS
TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 14: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: MAJOR MARKET FINDINGS
FIGURE 2: MARKET DYNAMICS
FIGURE 3: KEY MARKET TRENDS
FIGURE 4: PORTER'S FIVE FORCES ANALYSIS
FIGURE 5: GROWTH PROSPECT MAPPING
FIGURE 6: MARKET MATURITY ANALYSIS
FIGURE 7: MARKET CONCENTRATION ANALYSIS
FIGURE 8: VALUE CHAIN ANALYSIS
FIGURE 9: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, GROWTH POTENTIAL, BY DRUG TYPE, IN 2024
FIGURE 10: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY ANALGESICS, 2025-2032 (IN $ MILLION)
FIGURE 11: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY PAIN MANAGEMENT DRUGS, 2025-2032 (IN $ MILLION)
FIGURE 12: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY ANTI-INFLAMMATORY DRUGS, 2025-2032 (IN $ MILLION)
FIGURE 13: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY RESPIRATORY DRUGS, 2025-2032 (IN $ MILLION)
FIGURE 14: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY CARDIOVASCULAR DRUGS, 2025-2032 (IN $ MILLION)
FIGURE 15: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY VACCINES, 2025-2032 (IN $ MILLION)
FIGURE 16: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY OTHER DRUG TYPES, 2025-2032 (IN $ MILLION)
FIGURE 17: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, GROWTH POTENTIAL, BY DOSAGE FORM, IN 2024
FIGURE 18: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY SYRUPS, 2025-2032 (IN $ MILLION)
FIGURE 19: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY CAPSULES, 2025-2032 (IN $ MILLION)
FIGURE 20: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY TABLETS, 2025-2032 (IN $ MILLION)
FIGURE 21: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY POWDERS, 2025-2032 (IN $ MILLION)
FIGURE 22: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY OTHER DOSAGE FORMS, 2025-2032 (IN $ MILLION)
FIGURE 23: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2024
FIGURE 24: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY PHARMACIES, 2025-2032 (IN $ MILLION)
FIGURE 25: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY HOSPITALS, 2025-2032 (IN $ MILLION)
FIGURE 26: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, BY OTHER DISTRIBUTION CHANNELS, 2025-2032 (IN $ MILLION)
FIGURE 27: MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, COUNTRY OUTLOOK, 2024 & 2032 (IN %)
FIGURE 28: UNITED ARAB EMIRATES HALAL PHARMACEUTICALS MARKET, 2025-2032 (IN $ MILLION)
FIGURE 29: SAUDI ARABIA HALAL PHARMACEUTICALS MARKET, 2025-2032 (IN $ MILLION)
FIGURE 30: TURKEY HALAL PHARMACEUTICALS MARKET, 2025-2032 (IN $ MILLION)
FIGURE 31: EGYPT HALAL PHARMACEUTICALS MARKET, 2025-2032 (IN $ MILLION)
FIGURE 32: SOUTH AFRICA HALAL PHARMACEUTICALS MARKET, 2025-2032 (IN $ MILLION)
FIGURE 33: REST OF MIDDLE EAST & AFRICA HALAL PHARMACEUTICALS MARKET, 2025-2032 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security